Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 States
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 10/14/2024 | $66.00 | Buy | TD Cowen | |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | ||
| 7/24/2024 | $83.00 → $69.00 | Buy → Hold | Jefferies | |
| 7/11/2024 | $44.00 → $50.00 | Hold → Buy | Truist | |
| 5/30/2024 | $83.00 | Neutral | Robert W. Baird | |
| 5/30/2024 | $54.00 | Outperform | Robert W. Baird | |
| 3/21/2024 | $92.00 → $85.00 | Overweight → Equal-Weight | Stephens | |
| 3/6/2024 | $101.00 | Overweight | Barclays |
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
8-K - Astrana Health, Inc. (0001083446) (Filer)
8-K - Astrana Health, Inc. (0001083446) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00
KeyBanc Capital Markets initiated coverage of Astrana Health with a rating of Sector Weight
Jefferies downgraded Centene from Buy to Hold and set a new price target of $69.00 from $83.00 previously
SC 13G - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
ALHAMBRA, Calif., Nov. 8, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it and its affiliated professional entities have entered into a definitive agreement to acquire Prospect Health ("Prospect"), which consists of certain businesses and assets relating to Prospect Health System, including its California licensed health care service plan (Prospect Health Plan), medical groups in California, Texas, Arizona and Rhode Island (Pro
Company to Host Conference Call on Thursday, November 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Nov. 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the third quarter ended September 30, 2024. "Astrana's strong third quarter continues to reflect the outcomes we are
-- Diluted EPS of $1.36; Adjusted Diluted EPS of $1.62 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $1.62 in the third quarter of 2024.Premium and service revenues of $36.9 billion in the third quarter of 2024.Membership increases of 22% in Marketplace and 49% in Medicare Prescription Drug Plans, compared to the third quarter of 2023.Continued execution on capital deployment with $1.2 billion of share repurchases during the third quarter of 2024 and an additional $380 million in October, bringing full-year repurchases to $2.4 billion through October 2024.ST. LOUIS, Oct. 25, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the
ALHAMBRA, Calif., Nov. 21, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana"), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, is proud to announce that eight of its affiliates have been recognized as Elite status recipients in the 2024 Standards of Excellence™ (SOE®) survey by America's Physician Groups (APG). This annual comprehensive survey is administered by APG to evaluate which physician groups are best positioned to provide coordinated, patient-centered, and cost-effective care.
ALHAMBRA, Calif., Nov. 8, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it and its affiliated professional entities have entered into a definitive agreement to acquire Prospect Health ("Prospect"), which consists of certain businesses and assets relating to Prospect Health System, including its California licensed health care service plan (Prospect Health Plan), medical groups in California, Texas, Arizona and Rhode Island (Pro
Company to Host Conference Call on Thursday, November 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Nov. 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the third quarter ended September 30, 2024. "Astrana's strong third quarter continues to reflect the outcomes we are
PEMBROKE PINES, Fla., Nov. 7, 2024 /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE:CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024. Zein has nearly two decades of experience in the healthcare industry, including various leadership roles of increasing scope and responsibility at Sunshine Health since joining in 2019. She most recently served as Sunshine Health Chief Product President, where she had oversight of all of Sunshine Health's Medi
ST. LOUIS, Aug. 15, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today that it has appointed Thomas R. Greco to the Centene Board of Directors, effective Aug. 9, 2024. Mr. Greco's term will run through the Company's 2025 annual meeting of stockholders. The appointment of Mr. Greco expands Centene's Board of Directors to 11 members. Mr. Greco is a seasoned operator and executive who brings more than four decades of public company leadership and expertise to Centene. Over the course of his career, he has implemented growth strategies and fostered
TAMPA, Fla., July 31, 2024 /PRNewswire/ -- Big Brothers Big Sisters of America (BBBSA), the nation's preeminent one-to-one youth mentoring organization, today announced the election of its newest Board member, Centene Corporation [Centene] (NYSE:CNC) Executive Vice President (EVP) of External Affairs, Jonathan Dinesman. Centene, a leading healthcare enterprise focused on transforming the health of the communities it serves, has been a long-time partner of BBBSA. Dinesman oversees Federal and State Government Relations; Centene's political action committee; Public Policy; Strat
4 - Astrana Health, Inc. (0001083446) (Issuer)
4 - Astrana Health, Inc. (0001083446) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 States
Centene (NYSE:CNC) has outperformed the market over the past 20 years by 5.77% on an annualized basis producing an average annual return of 14.03%. Currently, Centene has a market capitalization of $34.60 billion. Buying $1000 In CNC: If an investor had bought $1000 of CNC stock 20 years ago, it would be worth $13,449.23 today based on a price of $64.84 for CNC at the time of writing. Centene's Performance Over Last 20 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and reviewed
TD Cowen analyst Gary Taylor maintains Centene (NYSE:CNC) with a Buy and lowers the price target from $91 to $80.
